Lifecare ASA — Regulatory Filings 2021

Oct 14, 2021

Lifecare nominated to the Industrial Advisory Board at MARSS conference

Lifecare nominated to the Industrial Advisory Board at MARSS conference

Bergen, 14.10.2021

Lifecare has been invited to take seat in the Industrial Advisory Board (IAB) at the 5th International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS) to be held in Toronto, Canada, July 18-22, 2022. Lifecare has accepted the invitation.

MARSS is the flagship event for cross-disciplinary R&D communities to discuss current activities in all areas related to manipulation and automation (including measurement and characterization) at micro & nano scales, and in all kinds of small-scale robots and their applications. The 5th annual MARSS is sponsored by the University of Toronto, the University of Oldenburg and the IEEE subdivisions IEEE Robotics & Automation Society and IEEE Nanotechnology Council Advancing Nanotech for Humanity. The IEEE is the world largest technical professional organization for the advancement of technology carrying the slogan “Advancing Technology for Humanity”.

The nomination of Lifecare to join the IAB of the MARSS conference is an appreciation of Lifecare’s interdisciplinary research and development within the fields of nanosensing, electronics, chemistry, and robotics employed by the company in the course of the Sencell sensor development. The already achieved miniaturization of Lifecare’s Sencell sensor for glucose detection is based on a 3DNanoprinting process, which allows to produce strain sensor elements at the size of a few tens of a nanometer (1 nanometer = 1 millionth of a millimeter) at the newly established Lifecare Nanobiosensors MEMS & Sensor Research Laboratory in Reutlingen (Germany). Lifecare Nanobiosensors holds a global license for the 3DNanoprinting technology making it possible to produce and market the complete overall Sencell device for continuous glucose monitoring at the size of a grain of rice.

Lifecare is honored by the invitation from the MARSS Steering Committee and looks forward to interacting with the conference participants to bridge the communication and support the joint development efforts between the industry, academia and other stakeholders.

More information of the MARSS conference can be found at https://marss-conference.org/

This is Lifecare

Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).

For further information, please contact: Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This stock exchange announcement was published by Kine Hereid, Investor Relations at Lifecare AS, on 14.10.2021 at 08:20 CET.